Skip to main content

Dalrada Corporation to add $10mm of profitable revenue with advanced homecare acquisition

By October 26, 2021August 13th, 2022No Comments

SAN DIEGO, CA – OCTOBER 26, 2021 – Dalrada Corporation (OTCQB: DFCO, “Dalrada”) announces that the Company has executed a letter of intent (LOI) to acquire Advanced DME Services, Inc. dba Advanced Homecare. A Southern California-based sleep apnea solutions provider, Advanced Homecare, has served nearly 40,000 patients since its inception in 2005. This acquisition creates a new subsidiary within Dalrada Health’s portfolio and allows Advanced Homecare to reach national clients with aggressive growth plans. It also expands Dalrada Health’s synergies with potential opportunities across its product & services portfolio.

As an innovation company, Dalrada and its subsidiaries provide value by making timely and impactful products & services available within health & wellness, information technology, and clean energy & industrial engineering markets. Sleep Apnea is a health condition that requires specialized equipment, education, training, and therapy to ensure a patient’s constant airflow while they sleep.

Brian Bonar, Chairman and CEO of Dalrada, shares, “For Dalrada, the acquisition of AHC aligns perfectly with making a difference in people’s lives through awareness, education, and streamlined healthcare solutions.”

Covered by national commercial insurance providers, including Tricare, Medicare, and Medi-Cal/Medicaid, Advanced Homecare operates online and from Los Angeles, Temecula, San Diego, and Orange Counties. As it relates to sleep apnea prognosis, technology & science, clinical training & education, Advanced Homecare operates in partnership with physicians, clinics, hospitals, and sleep centers. Advanced Homecare’s revenues have grown organically and consistently increasing year-over-year, particularly in calendar year 2020 with revenues of $10MM USD.

Gabe Quintanilla, Founder and CEO of Advanced Homecare, states, “The acquisition of Advanced Homecare by Dalrada Health paves the way for expansion into every major city in the U.S. to help Sleep Apnea patients on a national level.”

Since 2005, Advanced Homecare (AHC) has been dedicated to treating Obstructive Sleep Apnea (OSA). With its sole focus on aiding patients with OSA, AHC provides a unique and exclusive concierge-type service experience for streamlined sourcing of CPAP (Continuous Positive Airway Pressure), APAP (Automatic Continuous Positive Airway Pressure), BiPAP (BiLevel CPAP), Adaptive Servo Ventilation, and BiLevel ST equipment and replacement supplies. Choosing to only focus on OSA, AHC has propelled its service levels to heights that resulted in unparalleled success compared to other providers with a broad spectrum of medical equipment.

Only 10% of the affected population is currently treated for sleep apnea, leaving the majority undiagnosed or unaware of the condition.  The annual economic burden of undiagnosed sleep apnea among U.S. adults is approximately $149.6 billion, according to the American Academy of Sleep Medicine (AASM) and Frost & Sullivan.

Dalrada plans to perform thorough due diligence with the intent to complete the stock purchase and cash agreement within the next four (4) weeks.

Continuously building on its core life sciences, technology, and engineering practices, Dalrada operates under the tenet of bringing innovative products and services to a complex new world. As consumers, businesses, and governments seek alternative solutions, Dalrada’s subsidiaries respond with affordable, available, accessible, and impactful innovations.

For more information on Dalrada and its subsidiaries, visit


About Advanced Homecare

Since 2005, Advanced Homecare (AHC)’s dedicated staff has exclusively focused on treating Obstructive Sleep Apnea (OSA) from its offices throughout Southern California. Serving nearly 40,000 patients diagnosed with sleep apnea, AHC streamlines sourcing of OSA-related machines, accessories, and replacement supplies.

With its sole focus on OSA, AHC staff develop a relationship with each patient to learn their specific requirements. This level of personalized care has propelled AHC’s service levels to unparalleled heights, differentiating it from other broad-spectrum medical equipment suppliers. For additional details, visit


About Dalrada (DFCO)

With perseverance, valor, dedication, and vision, Dalrada Corporation is dedicated to tackling worldwide challenges of today and tomorrow.

Dalrada is a global company that operates under the tenet of creating impactful innovations that matter for the world. The Company works continually to produce disruptive solutions that bridge the gap of accessibility and accelerate positive change for current and future generations.

Established in 1982, the Company has since grown its footprint to include the business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies. Each of Dalrada’s subsidiaries actively produces affordable and accessible world-class solutions to global problems. For more information, please visit



Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.



# # #

Skip to content